Madonna del Piano:
Molinazzo di Monteggio (M1):
Molinazzo di Monteggio (M2):
We are glad to announce that recently (28-30 March 2012) we passed a 3-day FDA inspection successfully at both our manufacturing sites, Molinazzo di Monteggio and Madonna del Piano, without any observation.
Possibility to produce nanoparticles by super- critical fluid precipitation under fully cGMP conditions.